European Stocks Gain as Novo Nordisk Bounces Back From 2023 Lows

Bloomberg12-23 17:45

(Bloomberg) -- European equities edged higher, boosted by a rebound in Danish drugmaker Novo Nordisk A/S, while investors continue to monitor what the US rates outlook means for the region. The Stoxx...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2493076888?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/F7oiKsUWm_kgTPQJT9fSEw--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/bloomberg_markets_842/95b09ca9769f0fa25682d26af8b771d1","is_english":true,"pubTime":"2024-12-23 17:45","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2493076888","market":"us","top_or_hot":-1,"title":"European Stocks Gain as Novo Nordisk Bounces Back From 2023 Lows","media":"Bloomberg","content":"<div>\n<p>(Bloomberg) -- European equities edged higher, boosted by a rebound in Danish drugmaker Novo Nordisk A/S, while investors continue to monitor what the US rates outlook means for the region. \nThe Stoxx...</p>\n\n<a href=\"https://finance.yahoo.com/news/european-stocks-gain-novo-nordisk-094500394.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>European Stocks Gain as Novo Nordisk Bounces Back From 2023 Lows</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEuropean Stocks Gain as Novo Nordisk Bounces Back From 2023 Lows\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-23 17:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/european-stocks-gain-novo-nordisk-094500394.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) -- European equities edged higher, boosted by a rebound in Danish drugmaker Novo Nordisk A/S, while investors continue to monitor what the US rates outlook means for the region. \nThe Stoxx...</p>\n\n<a href=\"https://finance.yahoo.com/news/european-stocks-gain-novo-nordisk-094500394.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"https://finance.yahoo.com/news/european-stocks-gain-novo-nordisk-094500394.html","article_id":"2493076888","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/F7oiKsUWm_kgTPQJT9fSEw--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/bloomberg_markets_842/95b09ca9769f0fa25682d26af8b771d1"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2493076888","pubTimestamp":1734947100,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":" -- European equities edged higher, boosted by a rebound in Danish drugmaker Novo Nordisk A/S, while investors continue to monitor what the US rates outlook means for the region.The Stoxx Europe 600 Index gained 0.3% by 9:38 a.m. in London. Health care stocks outperformed as Novo rallied 9%, recovering from the previous session when it hit levels not seen since August 2023. Meanwhile, the travel and leisure sector slid as Evolution AB slumped after the UK Gambling Commission began a review of its Malta operations.Direct Line Insurance Group Plc rose after Aviva Plc agreed to buy the insurer in a deal valuing the firm at around 3.7 billion .European stocks are set for a drop in December — a month that’s historically been positive on average for the Stoxx 600 over the past three decades — amid concerns about the path of Federal Reserve policy, the outlook for tariffs from US President-elect Donald Trump and political uncertainty. The Stoxx 600 Index is up just about 5% this year, far beh","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","BK4007":"制药","BK4532":"文艺复兴科技持仓","BK4599":"减肥药","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","NVO":"诺和诺德","IE00BZ1G4Q59.USD":"LEGG MASON CLEARBRIDGE US EQUITY SUSTAINABILITY LEADER \"A\"(USD) INC (A)","LU0154236417.USD":"BGF US FLEXIBLE EQUITY \"A2\" ACC","BK4585":"ETF&股票定投概念"},"translate_title":"诺和诺德从2023年低点反弹，欧洲股市上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NVO":1},"content_text":"(Bloomberg) -- European equities edged higher, boosted by a rebound in Danish drugmaker Novo Nordisk A/S, while investors continue to monitor what the US rates outlook means for the region. \nThe Stoxx Europe 600 Index gained 0.3% by 9:38 a.m. in London. Health care stocks outperformed as Novo rallied 9%, recovering from the previous session when it hit levels not seen since August 2023. Meanwhile, the travel and leisure sector slid as Evolution AB slumped after the UK Gambling Commission began a review of its Malta operations. \nDirect Line Insurance Group Plc rose after Aviva Plc agreed to buy the insurer in a deal valuing the firm at around £3.7 billion ($4.7 billion).\nEuropean stocks are set for a drop in December — a month that’s historically been positive on average for the Stoxx 600 over the past three decades — amid concerns about the path of Federal Reserve policy, the outlook for tariffs from US President-elect Donald Trump and political uncertainty. The Stoxx 600 Index is up just about 5% this year, far behind the S&P 500 Index’s 24% gain.\nA Bloomberg survey showed the euro-area economy is expected to have weaker GDP growth next year than initially anticipated. \nDespite lukewarm returns, some market watchers are seeing green shoots for Europe, especially given how cheap its stocks have become. While the region is in a period of “significant transition,” according to Aneeka Gupta, director of macroeconomic research at WisdomTree, the euro zone could see a recovery from next spring as political uncertainty ebbs.\n“We anticipate a landscape characterized by lower interest rates, greater political intervention, a renewed emphasis on valuation, and diminished appeal for globally exposed sectors,” Gupta added.\nFor more on equity markets:\n\nHigher for Longer Is What Markets Need to Digest: Taking Stock\nM&A Watch Europe: Aviva Agrees 275p/Sh for Direct Line, L’Oreal\nUS Stock Futures Rise\n\nYou want more news on this market? Click here for a curated First Word channel of actionable news from Bloomberg and select sources. It can be customized to your preferences by clicking into Actions on the toolbar or hitting the HELP key for assistance. To subscribe to a daily list of European analyst rating changes, click here.\n--With assistance from Michael Msika and Jan-Patrick Barnert.\n©2024 Bloomberg L.P.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2493076888"}